Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing molecular and mechanistic literature without new empirical human data.
PubMed 38804287 · doi:10.3390/jox14020034
What was done
This narrative review synthesizes historical and contemporary literature on progesterone receptor membrane component 1 (PGRMC1) and its regulatory influence on human cytochrome P450 (CYP) enzymes. The authors outline nine subtopics covering xenobiotic and endogenous CYP-mediated metabolism, CYP-associated human disorders, the role of cytochrome b5, PGRMC1 molecular characterization (structure, expression, intracellular location, heme-binding, and dimerization), direct and indirect mechanisms of CYP modulation by PGRMC1, and current research challenges.
What was found
The abstract provides no quantitative data or specific numerical effect sizes. It describes qualitative findings indicating that PGRMC1 acts as a direct modulator of membrane-bound CYP hemoproteins and can alter drug detoxification as well as steroid and fatty acid metabolism through both direct interactions and indirect regulatory pathways.
Why it matters
Understanding PGRMC1-mediated CYP modulation clarifies how non-CYP partner proteins influence drug metabolism and endogenous homeostasis, which may help explain variability in xenobiotic clearance and related human metabolic disorders.
Limits
The abstract reports no new experimental or clinical measurements and does not include a systematic search methodology or quantitative meta-analysis. Information on specific CYP isoforms affected, effect magnitudes, and clinical relevance in human populations is absent from the abstract.
Cited by
- context Progesterone plays an important functional role in physiological detoxification pathways.